Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus pandemic | Uttarakhand COVID-19 recovery rate climbs to 71%

As many as 2,018 patients have recovered in Uttarakhand, taking the recovery rate to 71.48 percent in the state

June 29, 2020 / 01:35 PM IST
Representative image

Representative image

Amid the surging COVID-19 cases, Uttarakhand has reported a recovery rate of more than 71 percent for the first time since the outbreak of coronavirus in the state.

According to the data released by the Ministry of Health and Family Welfare on June 29, the state recorded 32 fresh COVID-19 cases on June 28, taking the state's tally to 2,823. Of these, as many as 2,018 patients have recovered, taking the recovery rate to 71.48 percent in the state.

Among the 32 fresh cases, 14 were reported in Nainital, followed by 10 in Dehradun, four in Tehri, two in Chamoli, and one each in Champawat and Rudraprayag, according to the state health department bulletin.

Meanwhile, a 65-year-old man who had tested positive for COVID-19 died at Neelkanth Hospital in Nainital's Haldwani on June 28. He was admitted to the hospital with gastric complaints, said the health bulletin.

The fatality pushed the death toll due to the disease to 38 in Uttarakhand.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

In India, the recovery rate of COVID-19 patients recorded at 58.56 percent on the day with 3,21,722 people recovered so far, said the health ministry.

India has registered 5,48,318 COVID-19 cases till date. The country has seen a surge of 3,57,783 infections from June 1 till date.

Out of the total coronavirus infections recorded in the country, the number of active cases stands at 2,10,12, while the death toll has climbed to 16,475.

(With inputs from PTI)

Follow our full coverage on COVID-19 here.
Moneycontrol News
first published: Jun 29, 2020 01:35 pm
ISO 27001 - BSI Assurance Mark